Becker's Healthcare January 22, 2025
Claire Wallace

Guardant Health has secured Medicare coverage from Palmetto for its blood test to monitor for disease recurrence in patients with colorectal cancer.

Guardant, a biotechnology company, provides a blood test on Guardant’s Smart Liquid Biopsy platform that uses epigenomic analysis to detect circulating tumor DNA to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Insurance, Medicare, Pharma / Biotech
How AI is streamlining cell and gene therapy manufacturing
Denali’s Data in Rare Enzyme Deficiency Keep It on Pace to Seek Speedy FDA Approval
Vertex challenger Sionna prices $191M IPO
Insights from JP Morgan 2025: Key trends shaping the pharma industry
Oral Metabolic Drug Acquired by Novo Nordisk Continues to Show Concerning Neuro Side Effects

Share This Article